|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-1-21
|
|
pubmed:abstractText |
Oral estrogen therapy increases venous thromboembolism risk among postmenopausal women. Although recent data showed transdermal estrogens may be safe with respect to thrombotic risk, the impact of the route of estrogen administration and concomitant progestogens is not fully established.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1524-4636
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
340-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19834106-Administration, Cutaneous,
pubmed-meshheading:19834106-Administration, Oral,
pubmed-meshheading:19834106-Aged,
pubmed-meshheading:19834106-Aged, 80 and over,
pubmed-meshheading:19834106-Drug Therapy, Combination,
pubmed-meshheading:19834106-Estrogen Replacement Therapy,
pubmed-meshheading:19834106-Estrogens,
pubmed-meshheading:19834106-Female,
pubmed-meshheading:19834106-France,
pubmed-meshheading:19834106-Humans,
pubmed-meshheading:19834106-Middle Aged,
pubmed-meshheading:19834106-Progestins,
pubmed-meshheading:19834106-Proportional Hazards Models,
pubmed-meshheading:19834106-Prospective Studies,
pubmed-meshheading:19834106-Questionnaires,
pubmed-meshheading:19834106-Risk Assessment,
pubmed-meshheading:19834106-Risk Factors,
pubmed-meshheading:19834106-Time Factors,
pubmed-meshheading:19834106-Venous Thromboembolism
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
|
|
pubmed:affiliation |
Inserm Unit 780, Cardiovascular Epidemiology Section, Cedex, France. marianne.canonico@inserm.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
